Dr. Mila Brum Ortigoza, MD, PhD

Dr. Ortigoza practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Ortigoza's NPI, 1730525544, was assigned on May 20, 2013. Dr. Ortigoza graduated from Icahn School of Medicine at Mount Sinai in 2013. Dr. Ortigoza holds New York license 277653.

Dr. Ortigoza's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Ortigoza's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Ortigoza is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ortigoza practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Ortigoza's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Ortigoza is licensed in New York.

CMS data shows 53 Medicare services from Dr. Ortigoza across 2 procedure codes in 2024, for 35 Medicare patients. Medicare paid $4,447 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 35 Medicare patients who saw Dr. Ortigoza in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have arthritis, and 75% have high blood pressure. 60% are also on Medicaid. Their average risk score is 3.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ortigoza's median patient age at 56, with 55% women.

In 2019, Dr. Ortigoza wrote 176 Medicare Part D claims. They cover 12 drugs, with $260,125 in total drug cost. In 2018, CMS named 267 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ortigoza for performance year 2024, reported as part of a group. Dr. Ortigoza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Ortigoza, published from 2012 to 2025. 2023 was the busiest year, with 5. The most frequent topics are COVID-19, SARS-CoV-2 and COVID-19 Serotherapy. Dr. Ortigoza has published most often in bioRxiv. Dr. Ortigoza's most frequent co-authors are Liise-Anne Pirofski, MD, Judith S. Hochman, MD and Mark J. Mulligan, MD.

Dmand AI links Dr. Ortigoza to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral.

CMS Open Payments shows 1 general payment to Dr. Ortigoza from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $42.

Dr. Ortigoza graduated from Icahn School of Medicine at Mount Sinai in 2013.